Results 211 to 220 of about 205,172 (310)
In this study, a targeting PFKFB4 biomimetic codelivery system is developed to improve paclitaxel efficacy by inducing ferroptosis in SCLC. This system enhances immune cell infiltration and cytokine secretion, activating anti‐tumor immunity. Combined with anti‐PD‐L1, it boosts immune responses, offering a novel therapeutic strategy for overcoming ...
Xiang Liu+9 more
wiley +1 more source
Racial and ethnic characteristics and cancer-specific survival in Primary Malignant Cardiac Tumors. [PDF]
Aloysius MM+8 more
europepmc +1 more source
The gut microbiome is a potential target for treating cardiovascular disease. It is found that prophylactic administration of Flavonifractor plautii or its metabolite desaminotyrosine (DAT) exerts pleiotropic cardioprotective effects via promoting cardiomyocyte survival and attenuating cardiac inflammation against myocardial ischemia/reperfusion (I/R ...
Heng Du+21 more
wiley +1 more source
Los rabdomiomas cardiacos son tumores benignos dependientes de las fibras musculares miocárdicas, los cuales usualmente son múltiples, pero tienden a disminuir tanto en número como en tamaño con el crecimiento, con una regresión espontánea en 90% de los ...
Rafael Lince+4 more
doaj
Outcomes of Octogenarians with Primary Malignant Cardiac Tumors: National Cancer Database Analysis. [PDF]
Rahouma M+8 more
europepmc +1 more source
A unique hydrogel based on extracellular matrix from fish swim bladder, which is suitable for transcatheter delivery and possesses remarkable reparative capabilities for treating heart failure, is developed. It emerges as a multi‐effect factor profoundly influencing inflammation regulation, angiogenesis, and myocardial metabolism.
Yulong Fu+9 more
wiley +1 more source
Unusual Case of Two Synchronous Intracavitary Primary Cardiac Tumors [PDF]
Rajwinder S. Jutley+3 more
openalex +1 more source
A CTGF‐LYTAC nanoplatform is developed to selectively degrade connective tissue growth factor (CTGF) in triple‐negative breast cancer (TNBC), inhibiting TGF‐β signaling and cell interactions in the tumor microenvironment (TME). This strategy effectively suppresses tumor growth and metastasis, outperforming antibody‐based therapy.
Jia‐Yi Lin+11 more
wiley +1 more source
Diagnosis and treatment of cardiac tumors. [PDF]
Imai T, Shimoi T, Kawai A, Yonemori K.
europepmc +1 more source
Cardiovascular magnetic resonance of cardiac tumors and masses. [PDF]
Gatti M+9 more
europepmc +1 more source